Addressing the challenges
Safe environment for ATMP manufacturing
ATMP manufacturing cannot rely on conventional pharmaceutical approaches. Processes must be engineered around the biological nature of the product and the regulatory framework governing advanced therapies.
-
Closed aseptic processing
Technologies that eliminate open handling steps enhance sterility assurance and reduce operator-dependent variability. Converting open manipulations into closed systems is a key enabler of safe ATMP production.
-
Grade A manufacturing environments
Isolator-based solutions provide validated Grade A conditions for fill & finish as well as critical upstream and downstream interventions. This ensures high contamination control while maintaining operational efficiency.